Replimune Group
REPL
54 hedge funds and large institutions have $289M invested in Replimune Group in 2018 Q3 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
56.82% more ownership
Funds ownership: 0% → 56.82% (+57%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$89.5M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$49.8M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$38.4M |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$21.6M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$16M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of Montreal
Toronto,
Ontario, Canada
| $9K | +$9.85K | +562 | New |
|
|
CHP
52
Cable Hill Partners
Portland,
Oregon
| $8K | +$10.5K | +600 | New |
|
|
CCA
53
Catalyst Capital Advisors
Huntington,
New York
| $6K | +$6.57K | +375 | New |
|
54
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | +$4.21K | +240 | New |
|
REPL Hedge Fund Activity: Q3 2018 in Review
54 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q3 2018, worth a combined $289M.
Buyers outnumbered sellers: 54 funds opened new REPL positions and 0 closed out — a net gain of 54 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Omega Fund Management, opening a new position worth an estimated $89.5M.
- 54 institutional investors held Replimune Group (REPL) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $289M of Replimune Group stock for Q3 2018.
- 54 funds opened new Replimune Group positions in Q3 2018 and 0 closed out, a net change of +54 holders.
- The largest Replimune Group buyer in Q3 2018 was Omega Fund Management, an estimated $89.5M added.
Based on aggregated 13F filings for Q3 2018.